CBIO Crescent Biopharma, Inc.

Fundamentals / CIK 0001253689 / USD

Crescent Biopharma, Inc. reported $15.00M in revenue and a net loss of $109.1M for the trailing twelve months ended September 30, 2026, with a -1216.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CBIO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$26.94M$13.47M$0-$144.9MFY 2016 Revenue: $18KFY 2016 Net Income: -$31.81M2016FY 2017 Net Income: -$33.28M2017FY 2018 Net Income: -$48.27M2018FY 2019 Net Income: -$57.89M2019FY 2020 Revenue: $10.16MFY 2020 Net Income: -$51.03M2020FY 2021 Revenue: $1.16MFY 2021 Net Income: -$63.43M2021FY 2022 Revenue: $75KFY 2022 Net Income: -$46.69M2022FY 2023 Revenue: $10KFY 2023 Net Income: -$36.90M2023FY 2024 Net Income: -$37.88M2024FY 2025 Revenue: $10.84MFY 2025 Net Income: -$153.9M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $10.84M -- $10K $75K $1.16M $10.16M -- -- -- $18K
Research & Development $138.1M $14.26M $20.07M $28.39M $47.49M $44.93M $47.03M $40.09M $24.10M $23.28M
Total Operating Expenses $163.5M $40.04M $39.29M $47.48M $64.61M $61.67M $61.39M $51.50M $33.93M $31.93M
Operating Income -$152.6M -$40.04M -$39.28M -$47.40M -$63.45M -$51.51M -$61.39M -$51.50M -$33.93M -$31.91M
EBITDA -$152.5M -$40.00M -$39.12M -$47.20M -$63.18M -$51.24M -$61.11M -$51.23M -$33.67M -$31.72M
Interest Expense $2.19M -- -- -- -- -- -- -- -- --
Income Before Tax -$151.9M -- -- -- -- -- -- -- -- --
Income Tax Expense $2.00M -- -- -- -- -- -- -- -- --
Net Income -$153.9M -$37.88M -$36.90M -$46.69M -$63.43M -$51.03M -$57.89M -$48.27M -$33.28M -$31.81M
Basic EPS -- -$59.00 -$58.00 -$89.00 -$123.00 -$112.00 -$134.00 -$118.00 -$113.00 -$150.00
Diluted EPS -- -$59.00 -$58.00 -$89.00 -$123.00 -$112.00 -$134.00 -$118.00 -$113.00 -$150.00
Basic Shares Outstanding -- 644.8K 633.4K 525.3K 514.5K 457.2K 432.5K 410.4K 294.0K 212.6K
Diluted Shares Outstanding -- 644.8K 633.4K 525.3K 514.5K 457.2K 432.5K 410.4K 294.0K 212.6K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $3.12M $0 $1.04M $10.84M $0 $0 $0 $0
Research & Development $34.30M $19.39M $17.90M $95.03M $20.35M $12.08M $10.63M $14.03M
Total Operating Expenses $43.02M $28.13M $25.77M $102.3M $25.89M $21.03M $14.22M $17.19M
Operating Income -$39.91M -$26.36M -$24.73M -$91.49M -$25.89M -$21.03M -$14.22M -$17.19M
EBITDA -$39.84M -$26.30M -$24.66M -$91.44M -$25.86M -$21.03M -$14.22M -$17.19M
Interest Expense $0 $0 $0 $0 $0 $1.07M $1.11M $852K
Income Before Tax -- -- -- -- -- -- -- -$17.87M
Income Tax Expense $0 $0 $0 $2.00M $0 $0 $0 $0
Net Income -$37.73M -$24.84M -$23.28M -$23.30M -$24.61M -$21.79M -$15.15M -$17.87M
Basic EPS -- -- -- -- -- -- -$4.00 --
Basic Shares Outstanding -- -- -- -- -- -- 645.2K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $213.2M $34.77M $41.79M $47.87M $90.25M $137.0M $158.2M $209.9M $123.9M $40.04M
Cash & Short-Term Investments $213.2M $34.77M $41.79M $47.87M $90.25M $137.0M $158.2M $209.9M $123.9M $40.04M
Accounts Receivable, Net $18.00M $0 -- -- -- -- -- -- -- --
Other Current Assets $5.46M $38K -- -- -- -- -- -- -- --
Total Current Assets $236.7M $34.80M $43.79M $50.71M $90.79M $138.3M $162.5M $212.3M $127.2M $40.52M
Property, Plant & Equipment, Net $846K $0 -- $242K $369K $621K $823K $957K $1.11M $1.06M
Other Non-Current Assets $1.22M $813K -- -- -- -- -- -- -- --
Total Non-Current Assets $3.64M $813K $1.53M $1.10M $3.56M $4.56M $5.44M $2.57M $1.36M $1.87M
Total Assets $240.3M $35.62M $45.32M $51.81M $94.35M $142.8M $168.0M $214.8M $128.6M $42.39M
Accounts Payable -- $329K $868K $970K $2.11M $2.09M $1.44M $2.66M $2.65M $1.57M
Deferred Revenue (Current) $4.16M $0 -- -- -- -- -- -- -- --
Total Current Liabilities $36.07M $9.61M $6.84M $8.88M $11.82M $12.43M $10.95M $8.76M $8.17M $6.33M
Total Non-Current Liabilities $1.21M $37.48M $67K $0 $919K $2.18M $2.82M $612K $707K $754K
Total Liabilities $37.28M $47.10M $6.90M $8.88M $12.74M $14.61M $13.77M $9.37M $8.88M $7.09M
Total Debt (incl. Leases) $1.64M $67K $808K $919K $1.92M $2.82M $3.62M -- -- --
Common Stock $28K $1.0K $64K $54K $52K $49K $43K $43K $34K $23K
Retained Earnings -$171.8M -$17.87M -$456.5M -$419.6M -$372.9M -$309.5M -$258.4M -$200.6M -$152.3M -$119.0M
Total Stockholders' Equity $203.0M -$15.48M $38.41M $42.93M $81.60M $128.2M $154.2M $205.5M $119.7M $35.30M
Total Equity $203.0M -$15.48M $38.41M $42.93M $81.60M $128.2M $154.2M $205.5M $119.7M $35.30M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $289.4M $171.6M $189.2M $213.2M $133.3M $152.6M $22.43M $34.77M
Cash & Short-Term Investments $289.4M $171.6M $189.2M $213.2M $133.3M $152.6M $22.43M $34.77M
Accounts Receivable, Net $0 $0 $0 $18.00M -- -- -- $0
Other Current Assets $5.85M $7.41M $6.40M $5.46M -- -- -- $38K
Total Current Assets $295.2M $179.0M $195.6M $236.7M $134.6M $154.2M $5.99M $34.80M
Property, Plant & Equipment, Net $809K $876K $929K $846K $782K $193K -- $0
Other Non-Current Assets $984K $1.50M $1.16M $1.22M $1.25M $1.30M -- $813K
Total Non-Current Assets $4.29M $3.75M $3.57M $3.64M $3.71M $3.21M $0 $813K
Total Assets $299.5M $182.8M $199.1M $240.3M $138.3M $157.4M $5.99M $35.62M
Accounts Payable -- -- -- -- -- -- $105K $329K
Deferred Revenue (Current) $0 $3.12M $3.12M $4.16M -- -- -- $0
Total Current Liabilities $23.49M $18.54M $14.19M $36.07M $20.30M $16.75M $2.62M $9.61M
Total Non-Current Liabilities $1.73M $966K $1.09M $1.21M $1.32M $1.43M $0 $37.48M
Total Liabilities $25.22M $19.50M $15.28M $37.28M $21.63M $18.18M $2.62M $47.10M
Total Debt (incl. Leases) $2.46M $1.44M $1.54M $1.64M $1.74M $1.64M -- $67K
Common Stock $38K $28K $28K $28K $14K $14K $65K $1.0K
Retained Earnings -$257.7M -$219.9M -$195.1M -$171.8M -$79.41M -$54.80M -$496.7M -$17.87M
Total Stockholders' Equity $274.3M $163.3M $183.8M $203.0M $116.6M $139.3M -$30.16M -$15.48M
Total Equity $274.3M $163.3M $183.8M $203.0M $116.6M $139.3M -$30.16M -$15.48M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$153.9M -$37.88M -$36.90M -$46.69M -$63.43M -$51.03M -$57.89M -$48.27M -$33.28M -$31.81M
Depreciation & Amortization $84K $35K $153K $207K $265K $271K $279K $275K $264K $191K
Stock-Based Compensation $13.30M $4.70M $3.52M $3.86M $6.09M $6.90M $6.22M $4.59M $3.76M $2.96M
Change in Receivables -$18.00M -- -- -- -- -- -- -- -- --
Change in Payables -- -$539K -$102K -$1.14M $18K $654K -$1.23M $16K $1.06M $1.00M
Operating Cash Flow -$71.53M -$31.10M -$34.88M -$46.46M -$57.49M -$39.24M -$51.98M -$43.33M -$29.77M -$29.73M
Capital Expenditure -$919K -$10.0K -$21K -$84K -$15K -$69K -$145K -$126K -$294K -$704K
Free Cash Flow -$72.45M -$31.11M -$34.90M -$46.54M -$57.50M -$39.31M -$52.13M -$43.46M -$30.06M -$30.44M
Investing Cash Flow -$72.92M $20K -$21K -$84K -$15K -$69K -$145K -$126K -$294K -$704K
Common Stock Issued $0 -- $28.71M $4.16M $10.70M $17.82M -- $128.4M $113.6M $23.60M
Financing Cash Flow $323.0M $5.4K $28.82M $4.16M $10.72M $18.14M $413K $129.4M $113.9M $23.67M
Net Change in Cash $178.5M -$31.07M -$6.08M -$42.38M -$46.78M -$21.17M -$51.72M $85.99M $83.88M -$6.76M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$37.73M -$24.84M -$23.28M -$23.30M -$24.61M -$21.79M -$2.34M -$7.22M
Depreciation & Amortization $67K $66K $64K $54K $28K $2.0K $0 $0
Stock-Based Compensation $4.22M $3.96M $4.11M $4.75M $1.99M $5.34M $1.23M $1.13M
Change in Receivables $0 $0 $18.00M -$18.00M $0 $0 $0 $0
Change in Payables -- -- -- -- -- -- -$225K -$252K
Operating Cash Flow -$26.94M -$19.46M -$8.94M -$26.74M -$17.54M -$16.40M -$10.85M -$6.27M
Capital Expenditure $0 -$13K -$147K -$193K -$586K -$140K $0 $0
Free Cash Flow -$26.94M -$19.48M -$9.08M -$26.93M -$18.12M -$16.54M -$10.85M -$6.27M
Investing Cash Flow $0 $1.76M -$8.15M -$72.19M -$586K -$140K $0 $0
Common Stock Issued -- -- -- -- -- -- -- $315K
Financing Cash Flow $144.8M $136K -$6.95M $178.9M -$1.25M $146.9M -$1.49M $41.03M
Net Change in Cash $117.9M -$17.57M -$24.03M $79.93M -$19.38M $130.3M -$12.34M $34.77M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -1407.5% -- -392752.9% -63204.4% -5470.7% -506.8% -- -- -- -172505.3%
Net Profit Margin -1419.6% -- -368994.2% -62251.7% -5469.0% -502.1% -- -- -- -171945.1%
Return on Equity (ROE) -75.8% -- -96.1% -108.8% -77.7% -39.8% -37.5% -23.5% -27.8% -90.1%
Return on Assets (ROA) -64.1% -106.4% -81.4% -90.1% -67.2% -35.7% -34.5% -22.5% -25.9% -75.0%
Current Ratio 6.56x 3.62x 6.41x 5.71x 7.68x 11.13x 14.84x 24.22x 15.56x 6.40x
Quick Ratio 6.41x 3.62x 6.11x 5.39x 7.63x 11.03x 14.45x 23.95x 15.16x 6.32x
Debt to Equity 0.01x -- 0.02x 0.02x 0.02x 0.02x 0.02x -- -- --
Revenue Growth (YoY) -- -- -86.7% -93.5% -88.6% -- -- -- -- -99.9%
5Y Revenue / Share Growth -- -- -- -- +2489.8% -78.9% -- -- -- --
10Y Revenue / Share Growth -- -- -100.0% -100.0% -- -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -- -- -- -108.6% --
10Y Net Income / Share Growth -- -- -- -106.8% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -1216.6% -1417.7% -1372.9% -1407.5% -- -- -- --
Net Profit Margin -727.6% -808.1% -782.5% -782.4% -- -- -- --
Return on Equity (ROE) -39.8% -58.8% -50.6% -41.8% -68.1% -46.4% -- --
Return on Assets (ROA) -36.4% -52.5% -46.7% -35.3% -57.4% -41.1% -883.4% -136.2%
Current Ratio 12.57x 9.66x 13.78x 6.56x 6.63x 9.21x 2.29x 3.62x
Quick Ratio 12.32x 9.26x 13.33x 6.41x 6.56x 9.12x 8.57x 3.62x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x -- --
Source: SEC EDGAR CompanyFacts (CIK 0001253689) · from December 31, 2012 Data through September 30, 2026 · synced Nov 20, 2026, 05:35 UTC · Open in terminal